Rm Market Size, Top Trends – Industry Revenue, Forecast To 2022-2030
February 10, 2023 ⚊ 1 Min read ⚊ Views 67 ⚊ BUSINESS
Regenerative Medicine (RM) market size was USD 9,800.00 Million in 2021 and is expected to register a revenue CAGR of 15.9% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of chronic diseases, such as cancer, Cardiovascular Diseases (CVD), and diabetes is a major factor driving market revenue growth.
The U.S. Food and Drug Administration (FDA) has approved regenerative medicines for a number of diseases, including melanoma, prostate cancer, damaged cartilage, lymphomas, spinal muscular atrophy, and Leber congenital amaurosis, among others. In 2022, over 15 stem cell therapies have been approved by FDA in 2022, which is expected to address a broad range of diseases, thereby rising demand for regenerative medicines among patients over the coming years and driving revenue growth of the regenerative medicines market.
